Randomized Study of Obicetrapib as an Adjunct to Statin Therapy
Public ClinicalTrials.gov record NCT04753606. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Placebo-Controlled, Double-Blind, Randomized, Phase 2 Dose-Finding Study to Evaluate the Effect of Obicetrapib as an Adjunct to High-Intensity Statin Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will be a placebo-controlled, double-blind, randomized, phase 2 dose-finding study to evaluate the efficacy, safety, and tolerability of obicetrapib as an adjunct to high-intensity statin therapy.
Study identification
- NCT ID
- NCT04753606
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 17, 2021
- Primary completion
- May 23, 2021
- Completion
- Aug 29, 2021
- Last update posted
- Jul 11, 2024
2021
United States locations
- U.S. sites
- 19
- U.S. states
- 13
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pinnacle Research Group | Anniston | Alabama | 36207 | — |
| National Research Institute - Huntington Park | Huntington Park | California | 90255 | — |
| National Research Institute - Wilshire | Los Angeles | California | 90057 | — |
| Clinical Trials Research | Sacramento | California | 95821 | — |
| Jacksonville Center for Clinical Research | Jacksonville | Florida | 32216 | — |
| Ocala Cardiovascular Research | Ocala | Florida | 34474 | — |
| Progressive Medical Research | Port Orange | Florida | 32127 | — |
| IACT Health | Columbus | Georgia | 31904 | — |
| Evanston Premier Healthcare Research LLC | Evanston | Illinois | 60201 | — |
| Midwest Institute for Clinical Research | Indianapolis | Indiana | 46260 | — |
| Oakland Medical Research Center | Troy | Michigan | 48085 | — |
| Diabetes and Endocrinology Consultants, P.C. | Morehead City | North Carolina | 28557 | — |
| Lillestol Research, LLC | Fargo | North Dakota | 58104 | — |
| Metabolic and Atherosclerosis Research Center | Cincinnati | Ohio | 45227 | — |
| Summit Research Group, LLC | Munroe Falls | Ohio | 44262 | — |
| Monument Health Clinical Research | Rapid City | South Dakota | 57701 | — |
| Health Concepts | Rapid City | South Dakota | 57702 | — |
| Juno Research, LL | Houston | Texas | 77040 | — |
| Manassas Clinical Research Center | Manassas | Virginia | 20110 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04753606, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 11, 2024 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04753606 live on ClinicalTrials.gov.